Concepedia

Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis

Nessrine Bellamri, M Lelong, Audrey Joannes, Erwan Le Tallec, S. Jouneau, Laurent Vernhet, Alain Lescoat, Valérie Lecureur

International Immunopharmacology · 2023 · 26 citations · 35 references

DOIFull text

Open access

Concepts

References

35

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu, Martine Rémy‐Jardin, Jeffrey L. Myers et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 4.1K citations

, , +17

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

T Ashcroft, Judy M. Simpson, V. Timbrell · Journal of Clinical Pathology · 1988 · 1.7K citations

, , +15

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

, , +13

World Medical Association Declaration of Helsinki

JAMA · 1997 · 1K citations

, , +2

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

Martin Herrmann, Reinhard Voll, Otmar Zoller et al. · Arthritis & Rheumatism · 1998 · 832 citations

, , +16